Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FIDAXOMICIN vs FILGRASTIM-AAFI: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FIDAXOMICIN vs FILGRASTIM-AAFI: Safety Overview

Metric FIDAXOMICIN FILGRASTIM-AAFI
Total FAERS Reports 1,491 439
Deaths Reported 181 80
Death Rate 12.1% 18.2%
Hospitalizations 410 117
Average Patient Age 63.7 yrs 54.8 yrs
% Female Patients 61.8% 60.0%
FDA Approval Date Feb 2, 2026 N/A
Manufacturer Merck Sharp & Dohme LLC N/A
Route ORAL N/A
Marketing Status Prescription Prescription